NCT04790084

Brief Summary

Explore the changes of choroidal blood perfusion in common fundus diseases by three-dimensional choroidal vascularity index, an optical coherence tomography (OCT) parameter.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
300

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Mar 2021

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 3, 2021

Completed
1 day until next milestone

Study Start

First participant enrolled

March 4, 2021

Completed
6 days until next milestone

First Posted

Study publicly available on registry

March 10, 2021

Completed
3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 10, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 10, 2024

Completed
Last Updated

March 10, 2021

Status Verified

March 1, 2021

Enrollment Period

3 years

First QC Date

March 3, 2021

Last Update Submit

March 6, 2021

Conditions

Choroid

Keywords

choroidal vascularity indexfundus diseasechoroidal blood flow

Outcome Measures

Primary Outcomes (1)

  • Three-dimensional choroidal vascularity index

    Three-dimensional choroidal vascularity index of healthy people and patients with common fundus diseases, based on optical coherence tomography.

    baseline, pre-intervention

Secondary Outcomes (1)

  • Choriocapillaris flow deficits%

    baseline, pre-intervention

Study Arms (1)

Healthy-Myopia-CSC

Cross-sectional study, no intervention, only collecting OCT,OCTA images and other eye parameters of patients.

Other: no intervention

Interventions

no interventionOTHER

no intervention

Healthy-Myopia-CSC

Eligibility Criteria

Age10 Years - 75 Years
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Chinese

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Renmin Hospital of Wuhan University

Wuhan, Hubei, 430000, China

RECRUITING

Central Study Contacts

CZ Chen, PHD

CONTACT

13072765173whuchenchzh@163.com

GP Sun, MD

CONTACT

15827084278sungongpeng@whu.edu.cn

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Chief of Department of Ophthalmology

Study Record Dates

First Submitted

March 3, 2021

First Posted

March 10, 2021

Study Start

March 4, 2021

Primary Completion

March 10, 2024

Study Completion

March 10, 2024

Last Updated

March 10, 2021

Record last verified: 2021-03

Locations

CN(1)